Michigan Medicine earns $2M grant for study on germ-killing robots

A research team led by Keith Kaye, MD, director of clinical research in the division of infectious disease at Ann Arbor-based Michigan Medicine, will assess the efficacy of Xenex Germ-Zapping Robots to eliminate drug-resistant bacteria in Detroit hospitals, according to a release.

The effort is backed by a $2 million, two-year grant from the NIH's Agency for Healthcare Research and Quality. Dr. Kaye will work with colleagues from Wayne State University in Detroit and Detroit Medical Center.

Researchers will measure the ability of high intensity ultraviolet light delivered the robots to eliminate germs related to infections like Clostridium difficile, vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.

The study is set to launch at Detroit Medical Center in May 2017, according to a media contact at the University of Michigan.

More articles on infection control: 
7 quotes from Robert F. Kennedy on Trump's proposed vaccine panel 
National cancer centers endorse CDC's updated HPV vaccine recommendations 
Detroit Medical Center passes surprise state inspection 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars